Johnson & Johnson seeks first drug approval for treatment of smoldering myeloma
STAT
DECEMBER 9, 2024
This roundup of news from the ASH 2024 conference first appeared in STAT’s “ASH in 30” newsletter. To get future editions, sign up here. Welcome back, ASH followers. Here’s your rundown of Monday’s news.
Let's personalize your content